论文部分内容阅读
1952—1973年间共收治甲状腺癌379例,男124例,女255例,其中,乳头状癌266例,滤泡癌62例,髓样癌16例,间变癌35倒。区域淋巴结转移率分别为51.1%、16.1%、62.5%及48.7%;远处转移率为3%、8%、25%及28.5%。主要采用外科治疗,其5年生存率分别为90.5%、90.9%、50%及18.7%;10年生存率为84.7%、69.4%、50%及15.4%。379例中治疗后因本病复发或转移而死亡78例,占20.6%,强调初次治疗时彻底控制肿瘤的重要性。治疗原发癌,主张行腺叶切除术,出现颈淋巴转移或乳头状癌的原发癌镜下已侵出包膜时,行颈淋巴结清除术。术后推荐长期服用甲状腺素。
Between 1952 and 1973, 379 cases of thyroid cancer were treated, including 124 males and 255 females. Among them, 266 cases were papillary carcinoma, 62 cases were follicular carcinomas, 16 cases were medullary carcinomas, and 35 were metastatic carcinomas. Regional lymph node metastasis rates were 51.1%, 16.1%, 62.5%, and 48.7%, respectively; distant metastases were 3%, 8%, 25%, and 28.5%. Surgical treatment was used. The 5-year survival rates were 90.5%, 90.9%, 50%, and 18.7%, respectively. The 10-year survival rates were 84.7%, 69.4%, 50%, and 15.4%. Among the 379 cases, 78 cases (20.6%) died due to the recurrence or metastasis of this disease after treatment, emphasizing the importance of complete control of the tumor during the initial treatment. Treatment of primary cancer, advocated lobectomy, cervical lymph node metastasis or papillary carcinoma under the primary cancerous capsule has invaded the capsule, the removal of cervical lymph nodes. Long-term use of thyroxine is recommended after surgery.